NJNikhil S. Joshi

Nikhil S. Joshi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Nikhil S. Joshi has a total of 381 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Early fate bias and TCR sequence shape CD8+ T cell differentiation and expansion

    by Ryan J. Brown, Yao Chen, Siying Lin, Jian Shen, Moujtaba Y. Kasmani, John Attanasio, Maria N. de Menezes, Achia Khatun, Ashley Zhu, Ian A. Parish, et al.

    When a naive CD8+ T cell encounters an antigen, it proliferates into descendants with identical T cell receptors (TCRs), termed clones. Whether their differentiation toward effector or memory fates is stochastic or TCR-dependent has remained unclear, largely because the vast diversity of TCRs makes individual clones difficult to trace over time. Using single-cell RNA and TCR sequencing in acute LCMV Armstrong infection, we found that clonal distributions in blood reflect those in lymphoid organs, enabling nonlethal longitudinal tracking of clonal evolution. Tracing hundreds of clones, we found that memory clonal distribution is surprisingly uncoupled from early dominance; instead, early central memory precursor frequency predicts memory dominance. Leveraging convergent recombination, we identified clones with identical CDR3 amino acid sequences in mice and found that these natural biological replicates were more likely than chance to adopt similar fates, although substantial clone-to-clone variation remained. Applying the TCR distance algorithm, we further identified dominant motifs associated with enhanced expansion and effector-biased transcriptional programs, extending the TCR’s role in shaping clonal differentiation.

  • Open Access

    Tetravalent dengue mRNA vaccination orchestrates balanced four-serotype immunity with durable memory and protection in mice.

    by Fahima Akther, Yago R. Dalben, John Villalpando, Kate Levine, Emma Buck, Jordan Polster, Zixi Yin, Hiromi Muramatsu, Sachchidanand Tiwari, Sowmya Sriram, et al.

    An effective dengue vaccine must establish durable immunity across four dengue virus (DENV) serotypes, evade antibody-dependent enhancement (ADE), and overcome immune imprinting from prior exposure. Here, we developed TetprM-E mRNA-LNP, a tetravalent vaccine comprising LNP-formulated nucleoside-modified mRNAs encoding DENV1-4 precursor membrane-envelope (prM-E) antigens, and evaluated its immunogenicity, durability, protection and breath across serotype-specific immune backgrounds. Three immunization strategies elicited neutralizing titers greater than 1:1500 against each serotype. Passive transfer of immune sera conferred 100% survival and reduced viremia after lethal DENV2 challenge in immunocompromised mice. Vaccination induced DENV envelope (env)-specific CD8+T cells and CD4-dependent germinal-center responses. DENV env-binding antibodies persisted for 34 weeks alongside DENV env-specific memory B cells. Vaccine-elicited sera showed no measurable in vitro ADE. Although monovalent priming initially biased antibody responses, TetprM-E mRNA-LNP vaccination broadened neutralization across DENV1-4 regardless of priming serotype. Together, TetprM-E mRNA-LNP elicits broad, durable, and protective immunity despite serologic constraints from pre-existing immunity.

  • Open Access

    A standardized method for T cell receptor (TCR) replacement through CRISPR-Cas9 mediated editing and retroviral transduction of primary murine naïve CD8 T cells

    by Nadine Martina Tong, John Attanasio, Eric Fagerberg, Kelli A Connolly, Nikhil S Joshi

    CD8 T cells play a central role in immune responses to infection and cancer. However, the diversity of T cell receptor (TCR) specificities makes it challenging to study the mechanisms that regulate T cell activation, differentiation, and effector function. Beyond TCR transgenic mouse models, various complex genome-editing approaches have been employed to overcome this challenge. However, these strategies are often technically demanding, time-intensive, and difficult to adapt. Investigators who are interested in testing de novo TCRs under their chosen experimental conditions would benefit from a standardized and accessible method. Here, we describe a protocol that combines ribonucleoprotein (RNP)-based CRISPR-Cas9 editing with retroviral transduction to enable efficient genetic manipulation of murine CD8 T cells. We show that T cells engineered via this protocol can be generated at sufficient scale for downstream in vitro assays and in vivo adoptive transfer experiments. We expect this method will be useful for investigators who require a standardized and accessible way to study how TCR specificity impacts CD8 T cell responses.

  • Top Cited Papers

    Dendritic cells control tertiary lymphoid structure development and maintenance in cancer

    by Raphaël Mattiuz, Jesse Boumelha, Emmanouil Aerakis, Jessica Le Berichel, Pauline Hamon, Laszlo Halasz, Abishek Vaidya, Brian Y. Soong, Emir Radkevich, Hye Mi Kim, et al.

    Tertiary lymphoid structures (TLSs) are associated with immunotherapy response, yet the mechanisms controlling their formation and maintenance remain unclear. Using spatial transcriptomics and multiplex imaging across human tumors, we found that CCR7 + mature dendritic cells (DCs) accumulate in TLSs. In a mouse non–small cell lung cancer model that forms mature TLSs, we show that early TLS development requires interferon-γ (IFN-γ)–driven type 1 conventional dendritic cell (cDC1) maturation, migration to tumor-draining lymph nodes (tdLNs), and T cell recruitment. As tumors progress, TLSs persist independently of tdLN T cell egress, coinciding with cDC1 accumulation within intratumoral CCL19 stromal hubs. There, cDC1–major histocompatibility complex class 1 (MHC-I) and –MHC-II concomitant antigen presentation, along with CD40 signaling, sustain TLS, T follicular helper (T FH ) cell pool, germinal centers, and tumor-specific immunoglobulin G (IgG). These findings highlight local mature cDC1s as key TLS orchestrators and potential targets to enhance antitumor TLS function.


  • Open Access

    Complementary constraints in germ and immune cells shape evolution of gene regulation and phenotype

    by Kimberly N Griffin, Kira L Marshall, Gabriel A Russell, John Attanasio, Delaney B Farris, Haoming Yu, Eric Fagerberg, Nivedita R Iyer, Rebecca Lee, Kaelyn D Sumigray, et al.

    New mutations arise in germ cells and must preserve fertility while altering somatic phenotype to confer a fitness advantage. To understand how whole organisms balance these constraints, we generated mice with humanized noncoding promoter sequence at Traf6 , an NF-κB pathway component with recently diverged chromatin state in mouse germ cells. The humanized allele (Traf6 h ) reinstated human-like expression in germ and immune cells, which we traced to a 13 base pair deletion that impairs CTCF binding. Traf6 h had no effect on fertility but induced a sensitized innate immune response to endotoxin. Other NF-κB pathway genes followed a similar pattern, suggesting that their expression has evolved in tandem and consistent with known mouse-human differences in inflammatory response. Our results reveal distinct roles for germ and immune cells in shaping gene regulatory evolution, where immune cells quickly adjust phenotype, enabling selection, while germ cells robustly maintain fertility despite changing expression levels, enabling inheritance.


  • Dissecting Tumor‐Associated Tertiary Lymphoid Structure Formation and Maintenance Using Mouse Models

    by Clémence Riffard, Zixi Yin, Kelli A. Connolly, Nikhil S. Joshi

    The solid tumor microenvironment is a highly complex system shaped by dynamic interactions among immune and non‐immune cell populations. The formation and organization of tumor‐associated tertiary lymphoid structures (TA‐TLS) have been observed in patients and linked to favorable prognosis and improved response to immunotherapy against a variety of cancers. Since then, preclinical mouse models have been extensively used to recapitulate TA‐TLS formation, dissect the underlying mechanisms, and define the cellular interactions licensing TLS anti‐tumor activity. Importantly, mouse models allow temporal dissection of TA‐TLS development and progression, an aspect that is difficult to capture in humans where analyses are typically limited to endpoint surgical material. Although many steps leading to TLS formation mirror secondary lymphoid organogenesis, a lot is left unknown about what initiates TA‐TLS formation and how these transient immune hubs can be manipulated therapeutically in cancer. Notably, while the persistence of TA‐TLS in the tumor microenvironment provides a prolonged local anti‐tumor immune response, it also enables the accumulation of regulatory cell components (regulatory T and B cells), thus making TLS the sites of both promotion and regulation of the ongoing endogenous immune response. The disruption of germinal centers and the progressive disaggregation of TLS following tumor regression and neoantigen clearance is also an important point where TLS differ from lymph nodes. Whether a form of local tissue memory exists following TA‐TLS resolution, and whether this memory allows for faster and more efficient response upon tumor rechallenge, remain open questions. Different preclinical tumor models used to address these questions have their own strengths and limitations. These models are empowered by advances in high‐dimensional imaging and spatial profiling technologies. The field of TA‐TLS is now reaching a turning point, where emerging techniques promise to help shift from mostly descriptive studies toward a more mechanistic and functional understanding of TLS biology in cancer. Here, we review insights gained from mouse models into TA‐TLS formation, persistence, and function, and highlight experimental and technological advances shaping future TLS research.


  • JoVE Video Dataset

    by H. N. Blackburn, J. Buck, Y. Qin, N. Joshi, R. A. Flavell

    Immunosurveillance versus antigen-tolerance is a fine balance within the gut microenvironment, during which the critical role of circulating T cell priming within local lymph nodes is well-known. Subsequent to T cell priming, recent literature has begun to demonstrate a unique, non-redundant role of non-circulating T cells residing in the draining lymph node of an organ. This may be particularly true in the gut, where lymph drainage is known to be highly specific. However, to truly understand the unique impact of these local cells versus systemic functional redundancy, the scientific community requires a well-described procedure to isolate and selectively perturb these nodes. Described here is a survival procedure for safe and well-tolerated murine mesenteric lymphadenectomy at each of four stations along the mesenteric lymph node chain. This procedure is adaptable to allow for selective disruption of lymphatic communication with the distal colon, proximal colon, and/or small intestine. Included are detailed instructions, visual aids, helpful tips for improved success, and troubleshooting for suboptimal survival. Resected lymph nodes are immediately ready for further downstream processing if desired. This technique is best suited for studies requiring selective disruption of lymph drainage from the distal colon, proximal colon, and/or small intestine.

  • Murine Mesenteric Lymphadenectomy for Selective Disruption of Lymphatic Communication with Region-Specific Gut

    by H. N. Blackburn, J. Buck, Y. Qin, N. Joshi, R. A. Flavell

    Immunosurveillance versus antigen-tolerance is a fine balance within the gut microenvironment, during which the critical role of circulating T cell priming within local lymph nodes is well-known. Subsequent to T cell priming, recent literature has begun to demonstrate a unique, non-redundant role of non-circulating T cells residing in the draining lymph node of an organ. This may be particularly true in the gut, where lymph drainage is known to be highly specific. However, to truly understand the unique impact of these local cells versus systemic functional redundancy, the scientific community requires a well-described procedure to isolate and selectively perturb these nodes. Described here is a survival procedure for safe and well-tolerated murine mesenteric lymphadenectomy at each of four stations along the mesenteric lymph node chain. This procedure is adaptable to allow for selective disruption of lymphatic communication with the distal colon, proximal colon, and/or small intestine. Included are detailed instructions, visual aids, helpful tips for improved success, and troubleshooting for suboptimal survival. Resected lymph nodes are immediately ready for further downstream processing if desired. This technique is best suited for studies requiring selective disruption of lymph drainage from the distal colon, proximal colon, and/or small intestine.

  • Open Access

    CD8 T cells mediate immunosurveillance for neoantigen+ epithelial stem cells in the colon

    by Jessica Buck, Nivedita R. Iyer, Eric Fagerberg, Goran Micevic, Jiaming He, Kerri St. Denis, Vyom Shah, Holly Nicole Blackburn, Srividhya Venkatesan, John Attanasio, et al.

    Summary: Epithelial cells in the colon accumulate substantial numbers of somatic mutations, some of which can be recognised as neoantigens. The ability of CD8 T cells to survey for neoantigen+ cells in the healthy colon would provide an early detection mechanism to prevent cancer, but it is unclear whether neoantigen-specific CD8 T cells can mediate this process of immunosurveillance without becoming tolerant. To address this question, we used a genetically engineered mouse model to express a neoantigen in the epithelial cells of the adult proximal colon. Induction of neoantigen expression led to rapid elimination of neoantigen+ epithelial cells from the colon in a CD8 T cell-dependent manner. Neoantigen-specific CD8 T cells acquired cytolytic function within the colon tissue under steady-state conditions, which was required for elimination of the neoantigen+ epithelial cells. Despite the elimination of ∼25% of their epithelial cells over a two-day period, the colons looked histologically normal. Immunofluorescence and single-cell transcriptomic analyses revealed that neoantigen-specific CD8+ T cells specifically target neoantigen+ stem cells at the crypt base, which was associated with Ki67 in the crypt wall and abundance of neoantigen-negative stem cells. Infiltrating neoantigen-specific CD8 T cells made IFNg and expressed PD-1, raising the question of why PD-1-dependent suppression did not prevent the acquisition of effector functions by these neoantigen-specific CD8 T cells. Despite an increased signature of interferon-stimulated genes in colonic epithelial cells, PD-L1 expression was surprisingly absent. Moreover, we found that colonic epithelial stem cells also did not express PD-L1 under conditions of chronic inflammation, such as ulcerative colitis, immune checkpoint-induced colitis, and ageing, or when directly stimulated with IFN-γ in vitro . Analyses of the PD-L1 gene promoter across humans and mice showed hypermethylation at sites associated with PD-L1 repression in cancer. Thus, our data support a model in which the acquisition of neoantigens by colonic epithelial cells triggers CD8 T cell-mediated immunosurveillance. This results in the elimination of PD-L1-negative neoantigen+ stem cells by effector CD8 T cells and simultaneous repair of the colon by neoantigen-negative epithelial cells to prevent immunopathology.


  • Distinct T cell functions enable efficient immunoediting and prevent tumor emergence of developing sarcomas

    by Julie F. Cheung, Brian G. Hunt, Shudipto Wahed, Elaine Cheng, Kelli A. Connolly, Srividhya Venkatesan, Jennifer L. Loza, Ishan Bansal, Eric Fagerberg, Emily A. Kessler, et al.